Pioglitazone to Treat Opioid Withdrawal Symptoms

NCT01517165 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

24

Enrollment

NIH

Sponsor class

Conditions

Opioid-Related Disorders

Interventions

DRUG: Pioglitazone
DRUG: Placebo

Sponsor

National Institute on Drug Abuse (NIDA)